{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:02:03Z","timestamp":1793840523660,"version":"4.6.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:p>Rituximab is an antibody that binds to B-lymphocytes and is increasingly used during pregnancy. As an immunoglobulin G, it will transfer across the placenta. Previous case reports describe a diversity of clinical presentations in neonates born following rituximab exposure in utero. Our case is the first to offer the long-term experience in the care of an infant with severe neutropenia and prolonged profound hypogammaglobulinemia and class-switching B cell defect after in utero rituximab exposure.<\/jats:p>","DOI":"10.1097\/mph.0000000000001871","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T07:32:33Z","timestamp":1593243153000},"page":"e601-e604","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Dysfunctional Immune System Reconstitution After Rituximab Exposure In Utero"],"prefix":"10.1097","volume":"43","author":[{"given":"Rebecca","family":"Clark","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Brooke Army Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lindsey","sequence":"additional","affiliation":[{"name":"Allergy and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Whiteway","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Brooke Army Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Mikita","sequence":"additional","affiliation":[{"name":"Allergy and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Lieuw","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Walter Reed National Military Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2010.08076.x","article-title":"The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases","volume":"149","author":"Cooper","year":"2010","journal-title":"British J Haematology"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jaci.2019.05.038","article-title":"Reference intervals for lymphocyte subsets in preterm and term neonates without immune defects","volume":"144","author":"Amatuni","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3109\/14767058.2015.1027680","article-title":"Reference values of serum IgG and IgM levels in preterm and term newborns","volume":"29","author":"Ozdemir","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1200\/JCO.1987.5.7.1098","article-title":"Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long term follow-up of children exposed in utero to chemotherapeutic agents","volume":"5","author":"Reynoso","year":"1987","journal-title":"J Clin Oncol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archinte.1992.00400150093017","article-title":"Fetal outcome after in utero exposure to cancer chemotherapy","volume":"152","author":"Zemlickis","year":"1992","journal-title":"Arch Intern Med"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830360404","article-title":"Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children","volume":"36","author":"Avil\u00e9s","year":"1991","journal-title":"Am J Hematology"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.autrev.2016.07.011","article-title":"Autoimmunity and infection in common variable immunodeficiency (CVID)","volume":"15","author":"Patuzzo","year":"2016","journal-title":"Autoimmunity Reviews"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14760584.2016.1115351","article-title":"Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy","volume":"15","author":"Ling","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","article-title":"Rituximab: mechanism of action","volume":"47","author":"Weiner","year":"2010","journal-title":"Semin Hematol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"e20162819","DOI":"10.1542\/peds.2016-2819","article-title":"Septic episodes in a premature infant after in utero exposure to rituximab","volume":"140","author":"Hay","year":"2017","journal-title":"Pediatrics"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/10428190500473113","article-title":"Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in consecutive series of 77 treatments","volume":"47","author":"Cattaneo","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2141.2003.04385.x","article-title":"Delayed-onset neutropenia associated with rituximab therapy","volume":"121","author":"Chaiwatanatorn","year":"2003","journal-title":"Br J Haematol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/ehm.11.62","article-title":"Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms","volume":"4","author":"Tesfa","year":"2011","journal-title":"Expert Rev Hematol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/cei.12001","article-title":"To B or not to B cells-mediate a healthy start to life","volume":"171","author":"Nguyen","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaip.2019.07.032","article-title":"Rituximab unveils hypogammaglobulinemia and immunodeficiency in children with autoimmune cytopenia","volume":"8","author":"Ottaviano","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.11.009","article-title":"Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease","volume":"57","author":"Roberts","year":"2015","journal-title":"J Autoimmun"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.autrev.2014.08.036","article-title":"Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systemic review of the literature","volume":"13","author":"Levy","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"e184169","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:12:54Z","timestamp":1754338374000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001871","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"2019-12-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}